Wall Street Experts
ver. ZuMIgo(08/25)
NeoPharm CO., LTD.
Rachunek Zysków i Strat
Przychody TTM (mln): 112 200
EBIT TTM (mln): 25 476
| index |
0 |
1 |
2 |
3 |
4 |
5 |
6 |
7 |
8 |
9 |
10 |
11 |
12 |
13 |
14 |
15 |
16 |
17 |
18 |
| Rok finansowy |
2006 |
2007 |
2008 |
2009 |
2010 |
2011 |
2012 |
2013 |
2014 |
2015 |
2016 |
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
2024 |
| Przychód (mln) |
11,454 |
5,767 |
12,477 |
14,609 |
14,661 |
16,944 |
18,774 |
20,138 |
25,603 |
35,965 |
42,369 |
53,634 |
66,275 |
83,240 |
81,625 |
87,931 |
85,033 |
97,105 |
119,014 |
| Przychód Δ r/r |
0.0% |
-49.7% |
116.4% |
17.1% |
0.4% |
15.6% |
10.8% |
7.3% |
27.1% |
40.5% |
17.8% |
26.6% |
23.6% |
25.6% |
-1.9% |
7.7% |
-3.3% |
14.2% |
22.6% |
| Marża brutto |
79.4% |
80.1% |
79.7% |
80.1% |
77.7% |
73.8% |
75.0% |
74.8% |
73.2% |
73.9% |
75.2% |
74.8% |
72.9% |
71.2% |
70.5% |
69.7% |
67.4% |
66.1% |
62.2% |
| EBIT (mln) |
3,423 |
1,600 |
3,492 |
1,960 |
304 |
1,199 |
-122 |
2,148 |
5,003 |
6,258 |
9,646 |
14,062 |
19,162 |
22,961 |
21,892 |
22,431 |
21,439 |
25,307 |
24,653 |
| EBIT Δ r/r |
0.0% |
-53.3% |
118.3% |
-43.9% |
-84.5% |
294.6% |
-110.2% |
-1862.2% |
132.9% |
25.1% |
54.1% |
45.8% |
36.3% |
19.8% |
-4.7% |
2.5% |
-4.4% |
18.0% |
-2.6% |
| EBIT (%) |
29.9% |
27.7% |
28.0% |
13.4% |
2.1% |
7.1% |
-0.6% |
10.7% |
19.5% |
17.4% |
22.8% |
26.2% |
28.9% |
27.6% |
26.8% |
25.5% |
25.2% |
26.1% |
20.7% |
| Koszty finansowe (mln) |
53 |
10 |
22 |
20 |
42 |
32 |
0 |
11 |
8 |
0 |
0 |
0 |
0 |
17 |
56 |
38 |
9 |
21 |
41 |
| EBITDA (mln) |
3,756 |
1,613 |
3,611 |
2,953 |
2,520 |
1,728 |
782 |
2,934 |
4,657 |
7,187 |
10,478 |
14,857 |
19,997 |
24,159 |
23,344 |
23,882 |
23,003 |
26,926 |
33,345 |
| EBITDA(%) |
32.8% |
28.0% |
28.9% |
20.2% |
17.2% |
10.2% |
4.2% |
14.6% |
18.2% |
20.0% |
24.7% |
27.7% |
30.2% |
29.0% |
28.6% |
27.2% |
27.1% |
27.7% |
28.0% |
| Podatek (mln) |
60 |
-264 |
-88 |
21 |
-334 |
-172 |
211 |
53 |
1,152 |
915 |
1,696 |
2,472 |
4,414 |
4,296 |
4,805 |
6,122 |
6,296 |
6,160 |
7,144 |
| Zysk Netto (mln) |
3,508 |
1,797 |
3,286 |
2,055 |
1,290 |
904 |
648 |
1,895 |
2,568 |
3,407 |
7,742 |
11,559 |
15,370 |
19,245 |
18,131 |
17,713 |
17,027 |
23,213 |
23,065 |
| Zysk netto Δ r/r |
0.0% |
-48.8% |
82.8% |
-37.5% |
-37.2% |
-29.9% |
-28.4% |
192.6% |
35.5% |
32.7% |
127.2% |
49.3% |
33.0% |
25.2% |
-5.8% |
-2.3% |
-3.9% |
36.3% |
-0.6% |
| Zysk netto (%) |
30.6% |
31.2% |
26.3% |
14.1% |
8.8% |
5.3% |
3.5% |
9.4% |
10.0% |
9.5% |
18.3% |
21.6% |
23.2% |
23.1% |
22.2% |
20.1% |
20.0% |
23.9% |
19.4% |
| EPS |
1992.31 |
902.56 |
505.0 |
307.0 |
174.0 |
122.0 |
87.0 |
258.0 |
361.0 |
482.0 |
1094.0 |
1617.0 |
2172.55 |
2569.66 |
2318.34 |
2264.94 |
2177.2 |
2968.15 |
1473.56 |
| EPS (rozwodnione) |
1992.31 |
902.56 |
505.0 |
307.0 |
174.0 |
122.0 |
87.0 |
258.0 |
361.0 |
482.0 |
1094.0 |
1617.0 |
2149.87 |
2544.31 |
2296.43 |
2264.94 |
2177.2 |
2968.15 |
1473.56 |
| Ilośc akcji (mln) |
2 |
2 |
7 |
7 |
7 |
7 |
7 |
7 |
7 |
7 |
7 |
7 |
7 |
7 |
8 |
8 |
8 |
8 |
16 |
| Ważona ilośc akcji (mln) |
2 |
2 |
7 |
7 |
7 |
7 |
7 |
7 |
7 |
7 |
7 |
7 |
7 |
8 |
8 |
8 |
8 |
8 |
16 |
| Waluta |
KRW |
KRW |
KRW |
KRW |
KRW |
KRW |
KRW |
KRW |
KRW |
KRW |
KRW |
KRW |
KRW |
KRW |
KRW |
KRW |
KRW |
KRW |
KRW |